Cargando…

Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary

BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bow...

Descripción completa

Detalles Bibliográficos
Autores principales: Lontai, Livia, Kürti, Zsuzsanna, Gonczi, Lorant, Komlódi, Nóra, Balogh, Fruzsina, Iliás, Ákos, Lakatos, Peter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334671/
https://www.ncbi.nlm.nih.gov/pubmed/36620930
http://dx.doi.org/10.5152/tjg.2023.22339
_version_ 1785070909023846400
author Lontai, Livia
Kürti, Zsuzsanna
Gonczi, Lorant
Komlódi, Nóra
Balogh, Fruzsina
Iliás, Ákos
Lakatos, Peter L.
author_facet Lontai, Livia
Kürti, Zsuzsanna
Gonczi, Lorant
Komlódi, Nóra
Balogh, Fruzsina
Iliás, Ákos
Lakatos, Peter L.
author_sort Lontai, Livia
collection PubMed
description BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bowel disease center. METHODS: Consecutive inflammatory bowel disease patients (n = 161, Crohn’s disease: 118/ulcerative colitis: 43; biological therapy: 70%) were included and followed up for 1 year between January and December 2018. Data on clinical disease activity, biomarkers, endoscopy, imaging, outpatient visits, treatment optimization, hospitalization, and surgery were collected. We compared the monitoring strategy according to the clinical activity (remission/flare/post-flare/continuous activity) every 3 months (assessment period). RESULTS: In total, n = 644 assessment periods were evaluated. Biomarkers were evaluated in 82.9%-83.9% of patients in each assessment period regardless of clinical activity. Colonoscopy was more frequently performed in active disease (flare/continuous disease activity: 21.1%/18.9% vs. clinical remission: 10.1% per assessment period). Magnetic resonance imaging was performed in 7.7%-16.7%/period in Crohn’s disease patients, while the use of computed tomography was low (2.4%/period) and mainly performed in active disease. Treatment optimization was more frequent in patients with active disease (biological start/dose optimization: 31.1%/33.8%/period, steroid start: 13.2%/period). Patients with continuous activity (2.62), flare (2.45), and post-flare (2.05) had higher mean patient visit counts compared to remission (1.68/period). CONCLUSIONS: Objective monitoring strategy was applied with routine assessment of clinical activity and biomarkers. Fast-track colonoscopic evaluations were adapted to the clinical stage of the disease while screening colonoscopies and magnetic resonance imaging were frequently used. Objective monitoring resulted in the early optimization of medical therapy and frequent specialist follow-up visits.
format Online
Article
Text
id pubmed-10334671
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Turkish Society of Gastroenterology
record_format MEDLINE/PubMed
spelling pubmed-103346712023-07-12 Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary Lontai, Livia Kürti, Zsuzsanna Gonczi, Lorant Komlódi, Nóra Balogh, Fruzsina Iliás, Ákos Lakatos, Peter L. Turk J Gastroenterol Original Article BACKGROUND: Emerging data suggest that a treat-to-target approach and early therapeutic intervention using regular objective disease assessment leads to improved outcomes. Our aim was to evaluate the value of objective disease monitoring during regular follow-up in a single tertiary inflammatory bowel disease center. METHODS: Consecutive inflammatory bowel disease patients (n = 161, Crohn’s disease: 118/ulcerative colitis: 43; biological therapy: 70%) were included and followed up for 1 year between January and December 2018. Data on clinical disease activity, biomarkers, endoscopy, imaging, outpatient visits, treatment optimization, hospitalization, and surgery were collected. We compared the monitoring strategy according to the clinical activity (remission/flare/post-flare/continuous activity) every 3 months (assessment period). RESULTS: In total, n = 644 assessment periods were evaluated. Biomarkers were evaluated in 82.9%-83.9% of patients in each assessment period regardless of clinical activity. Colonoscopy was more frequently performed in active disease (flare/continuous disease activity: 21.1%/18.9% vs. clinical remission: 10.1% per assessment period). Magnetic resonance imaging was performed in 7.7%-16.7%/period in Crohn’s disease patients, while the use of computed tomography was low (2.4%/period) and mainly performed in active disease. Treatment optimization was more frequent in patients with active disease (biological start/dose optimization: 31.1%/33.8%/period, steroid start: 13.2%/period). Patients with continuous activity (2.62), flare (2.45), and post-flare (2.05) had higher mean patient visit counts compared to remission (1.68/period). CONCLUSIONS: Objective monitoring strategy was applied with routine assessment of clinical activity and biomarkers. Fast-track colonoscopic evaluations were adapted to the clinical stage of the disease while screening colonoscopies and magnetic resonance imaging were frequently used. Objective monitoring resulted in the early optimization of medical therapy and frequent specialist follow-up visits. Turkish Society of Gastroenterology 2023-05-01 /pmc/articles/PMC10334671/ /pubmed/36620930 http://dx.doi.org/10.5152/tjg.2023.22339 Text en © 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Original Article
Lontai, Livia
Kürti, Zsuzsanna
Gonczi, Lorant
Komlódi, Nóra
Balogh, Fruzsina
Iliás, Ákos
Lakatos, Peter L.
Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title_full Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title_fullStr Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title_full_unstemmed Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title_short Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary
title_sort objective disease monitoring strategies from a tertiary inflammatory bowel disease center in hungary
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334671/
https://www.ncbi.nlm.nih.gov/pubmed/36620930
http://dx.doi.org/10.5152/tjg.2023.22339
work_keys_str_mv AT lontailivia objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT kurtizsuzsanna objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT gonczilorant objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT komlodinora objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT baloghfruzsina objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT iliasakos objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary
AT lakatospeterl objectivediseasemonitoringstrategiesfromatertiaryinflammatoryboweldiseasecenterinhungary